CN Patent
CN116133662A — 氮杂环丁烷取代化合物的晶型
Assigned to Medshine Discovery Inc · Expires 2023-05-16 · 3y expired
What this patent protects
一种式(I)所示的氮杂环丁烷取代化合物的晶型及其制备方法,还包括所述晶型在制备治疗癌症药物中的应用。
USPTO Abstract
一种式(I)所示的氮杂环丁烷取代化合物的晶型及其制备方法,还包括所述晶型在制备治疗癌症药物中的应用。
Drugs covered by this patent
- Krazati (ADAGRASIB) · Bristol-Myers Squibb
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.